Skip to main content
. Author manuscript; available in PMC: 2017 Dec 20.
Published in final edited form as: Antivir Ther. 2015 Apr 23;20(8):855–863. doi: 10.3851/IMP2963

Figure 1.

Figure 1

Algorithm showing ART initiation and discontinuation among 389 subjects enrolled with primary HIV-1 infection

aIndicates highly active antiretroviral therapy (HAART) as first treatment with no preceding non-HAART antiretroviral (ART) regimen. bEvaluable subjects had HIV-1 RNA below the limit of assay quantitation prior to interruption, at least 2 weeks of interruption, and an HIV-1 RNA measurement prior to any treatment re-initiation.